Ubs Asset Management Americas Inc Sorrento Therapeutics, Inc. Transaction History

Ubs Asset Management Americas Inc

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$1.24 - $2.33 $12,524 - $23,533	10,100 Added 3.94%	266,443 $535,000
Q4 2021 Feb 14, 2022	SELL	$4.65 - $7.23 $211,830 - $329,362	-45,555 Reduced 15.09%	256,343 $1.19 Million
Q3 2021 Nov 15, 2021	SELL	$7.41 - $10.99 $62,266 - $92,348	-8,403 Reduced 2.71%	301,898 $2.3 Million
Q2 2021 Aug 16, 2021	BUY	$6.35 - $10.0 $516,902 - $814,020	81,402 Added 35.56%	310,301 $3.01 Million
Q1 2021 May 14, 2021	BUY	$7.03 - $16.51 $62,447 - $146,658	8,883 Added 4.04%	228,899 $1.89 Million
Q4 2020 Mar 01, 2021	BUY	$5.76 - $11.95 $570,182 - $1.18 Million	98,990 Added 81.79%	220,016 $1.5 Million
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $34,200 - $104,319	5,543 Added 4.8%	121,026 $1.35 Million
Q2 2020 Aug 14, 2020	BUY	$1.73 - $6.76 $199,785 - $780,665	115,483 New	115,483 $725,000
Q4 2019 Feb 14, 2020	SELL	$1.45 - $4.17 $70,761 - $203,500	-48,801 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$2.05 - $2.69 $8,394 - $11,015	-4,095 Reduced 7.74%	48,801 $104,000
Q2 2019 Aug 15, 2019	BUY	$2.67 - $4.38 $39,897 - $65,450	14,943 Added 39.37%	52,896 $0
Q1 2019 May 14, 2019	BUY	$1.86 - $5.94 $7,254 - $23,166	3,900 Added 11.45%	37,953 $0
Q4 2018 Feb 13, 2019	BUY	$2.01 - $4.24 $25,030 - $52,800	12,453 Added 57.65%	34,053 $81,000
Q2 2018 Aug 14, 2018	BUY	$4.75 - $8.0 $102,600 - $172,800	21,600 New	21,600 $0

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

Stay updated on Ubs Asset Management Americas Inc with notifications on news.